These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 3128363)
21. Varicella vaccination in Italy : an economic evaluation of different scenarios. Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030 [TBL] [Abstract][Full Text] [Related]
22. Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean--a systematic review and meta-analysis. Bardach A; Cafferata ML; Klein K; Cormick G; Gibbons L; Ruvinsky S Pediatr Infect Dis J; 2012 Dec; 31(12):1263-8. PubMed ID: 23188098 [TBL] [Abstract][Full Text] [Related]
23. Chickenpox immunisation in New Zealand. Tobias M; Reid S; Lennon D; Meech R; Teele DW N Z Med J; 1998 Jul; 111(1070):274-81. PubMed ID: 9734530 [TBL] [Abstract][Full Text] [Related]
24. Epidemiology of chickenpox in France (1991-1995). Deguen S; Chau NP; Flahault A J Epidemiol Community Health; 1998 Apr; 52 Suppl 1():46S-49S. PubMed ID: 9764272 [TBL] [Abstract][Full Text] [Related]
25. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations. Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369 [TBL] [Abstract][Full Text] [Related]
26. Universal varicella vaccination increased the incidence of herpes zoster in the child-rearing generation as its short-term effect. Toyama N; Shiraki K; J Dermatol Sci; 2018 Oct; 92(1):89-96. PubMed ID: 30041832 [TBL] [Abstract][Full Text] [Related]
27. The incidence of chickenpox in the community. Lessons for disease surveillance in sentinel practice networks. Fleming DM; Schellevis FG; Falcao I; Alonso TV; Padilla ML Eur J Epidemiol; 2001; 17(11):1023-7. PubMed ID: 12380716 [TBL] [Abstract][Full Text] [Related]
28. Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil. Scotta MC; Paternina-de la Ossa R; Lumertz MS; Jones MH; Mattiello R; Pinto LA Vaccine; 2018 Jan; 36(2):280-284. PubMed ID: 29198917 [TBL] [Abstract][Full Text] [Related]
29. [Chickenpox in Poland in 2009]. Paradowska-Stankiewicz I Przegl Epidemiol; 2011; 65(2):195-7. PubMed ID: 21913458 [TBL] [Abstract][Full Text] [Related]
30. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115 [TBL] [Abstract][Full Text] [Related]
31. [Immunization of adults against varicella and herpes zoster]. Hanslik T; Blanchon T; Alvarez FP Rev Med Interne; 2007 Mar; 28(3):166-72. PubMed ID: 17270316 [TBL] [Abstract][Full Text] [Related]
32. The impact of MMR vaccine on mumps infection in England and Wales. Jones AG; White JM; Begg NT CDR (Lond Engl Rev); 1991 Aug; 1(9):R93-6. PubMed ID: 1669792 [TBL] [Abstract][Full Text] [Related]
33. Mass vaccination to control chickenpox: the influence of zoster. Ferguson NM; Anderson RM; Garnett GP Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7231-5. PubMed ID: 8692974 [TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster. Littlewood KJ; Ouwens MJ; Sauboin C; Tehard B; Alain S; Denis F Clin Ther; 2015 Apr; 37(4):830-841.e7. PubMed ID: 25721380 [TBL] [Abstract][Full Text] [Related]
35. Economic evaluation of vaccination programs: the impact of herd-immunity. Brisson M; Edmunds WJ Med Decis Making; 2003; 23(1):76-82. PubMed ID: 12583457 [TBL] [Abstract][Full Text] [Related]
36. [Varicella vaccination: who should be vaccinated these days?]. Hügle B; Suchowerskyj P; Schuster V MMW Fortschr Med; 2005 Feb; 147(8):31-2, 34-5. PubMed ID: 18441563 [TBL] [Abstract][Full Text] [Related]
37. Shift in age in chickenpox. Miller E; Vardien J; Farrington P Lancet; 1993 Jan; 341(8840):308-9. PubMed ID: 8093945 [No Abstract] [Full Text] [Related]
39. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458 [TBL] [Abstract][Full Text] [Related]